Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.

Biotechnology

Health & Wellness

Amicus Therapeutics

The Philadelphia office focuses on clinical research, regulatory affairs, and marketing for innovative therapies and treatments.

Philadelphia

The Princeton office focuses on leadership in patient advocacy, global security, and enhancing patient experience.

Princeton

Amicus Therapeutics' headquarters in Cranbury Township, NJ, United States

Bradley L. Campbell

David Clark

Sébastien Martel

Sam Pierre-Louis

Andrew Faughnan

Aurelien le Thiec

Jeff Castelli

Fermin Rivas

Richard Taylor

Paul Howard

Assad Meyer

Diana Moore

Mike Keavany

Pat Osullivan

Tricia Sterling

Ryan Graham

Joon Chung

Heather Ramirez

Jill Weimer

Patrik Florencio

Jayne C. Gershkowitz

Jeffrey P. Castelli

Machelle Manuel

Robert Essner

Margaret G. Mcglynn

Glenn P. Sblendorio

Eiry W. Roberts

Burke W. Whitman

Lynn D. Bleil

Craig A. Wheeler

Michael G. Raab

This department oversees clinical operations, medical affairs, and regulatory compliance to ensure the development and management of medical products.

Clinical Operations and Affairs

The Leadership Team at Amicus Therapeutics drives the strategic direction and operational execution of the company, overseeing key areas such as research and development, regulatory affairs, compliance, and human resources. This diverse group of executives collaborates to advance the company's mission of developing innovative treatments for rare and orphan diseases, ensuring alignment between scientific goals, patient needs, and business objectives. Their collective expertise fosters a culture of compliance, innovation, and compassion within the organization.

Leadership Team

This department focuses on the development and implementation of strategies to support and improve outcomes for patients with rare diseases.

Rare Disease Management

The Clinical Research Team at Amicus Therapeutics is responsible for designing, planning, and overseeing clinical trials to evaluate the safety and efficacy of therapies for rare and orphan diseases. This multidisciplinary team collaborates with medical affairs professionals and patient support services to ensure that clinical development aligns with patient needs and regulatory standards, driving innovations that improve outcomes for individuals with these challenging conditions.

Clinical Research Team

The Regulatory and Compliance Team at Amicus Therapeutics is responsible for ensuring that the company adheres to all regulatory requirements and compliance standards throughout the development and commercialization of its innovative therapies. This team collaborates closely with various departments to oversee quality assurance, conduct compliance audits, and navigate the regulatory landscape, ultimately ensuring that the company's products meet safety and efficacy standards for patients with rare and orphan diseases.

Regulatory and Compliance Team

This department oversees the strategic direction and overall management of the organization.

Executive Leadership

Amicus Therapeutics

Org chart

Board & advisors

Teams

Clinical Operations and Affairs

Leadership Team

Rare Disease Management

Clinical Research Team

Regulatory and Compliance Team

Executive Leadership

Offices

Amicus Therapeutics

Org chart

Board & advisors

Teams

Clinical Operations and Affairs

Leadership Team

Rare Disease Management

Clinical Research Team

Regulatory and Compliance Team

Executive Leadership

Offices

Related companies